Suzuki et al. [220] revealed that after chemoradiation therapy and induced HMGB1 levels in esophageal squamous cell carcinoma (ESCC) patients’ serum, tumor antigen-specific T-cell responses in these patients were induced. Here, HMGB1 is linked to esophageal squamous cell carcinoma.